Balance Sheet Components - Additional Information (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Apr. 30, 2025 |
Jun. 28, 2024 |
|
| Deferred Government Grants [Line Items] | |||||||
| Percentage of equity interest | 18.35% | ||||||
| Total investment | $ 1,800 | $ 1,800 | $ 1,700 | ||||
| Long-term investments | 1,599 | 1,599 | 1,591 | ||||
| Depreciation expense | 1,100 | $ 800 | 1,800 | $ 1,300 | |||
| Affiliates | |||||||
| Deferred Government Grants [Line Items] | |||||||
| Long-term investments | $ 1,600 | $ 1,600 | $ 1,600 | ||||
| Maximum | |||||||
| Deferred Government Grants [Line Items] | |||||||
| Investment obligation amount | $ 4,400 | ||||||
| Percentage of equity interest | 18.93% | ||||||
| X | ||||||||||
- Definition Deferred government grants. No definition available.
|
| X | ||||||||||
- Definition Investment subscription amount. No definition available.
|
| X | ||||||||||
- Definition Percentage of equity interest. No definition available.
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|